Keyword: Drug Discovery

News

CatSci Appoints Paul Bradley as Head of Business Development

28.06.2018 - CatSci, a UK-based process research and development contract research organization, announced the appointment of Paul Bradley as its new head of business development. Bradley joins...

News

UK and Canada Link in Antibacterial Drug Project

12.07.2017 - LifeArc, the UK medical research charity previously known as MRC Technology, is to collaborate with the government’s Defence Science and Technology Laboratory (Dstl) and Canada’s...

News

GSK and Regeneron Back UK Biobank Project

29.03.2017 - UK drugmaker GlaxoSmithKline (GSK) and US biotech Regeneron Pharmaceuticals are investing in a gene sequencing project that uses anonymous patient data held by the UK Biobank. The...

News

Cancer Research UK and HitGen in Pact

03.03.2017 - Cancer Research UK, its commercial arm Cancer Research Technology (CRT) and Chinese life science company HitGen have entered into a license agreement to develop a novel class of...

News

Pfizer and IBM in e-Health Alliance

19.12.2016 - Major US drugmaker Pfizer will use IBM Watson Health’s artificial intelligence technology to help in its efforts to find new cancer medicines. The deal will use the Watson for Drug...

News

Novartis Axes Swiss and Chinese R&D Sites

10.10.2016 - As part of a “broader, global strategic plan” to centralize control over its drug discovery programs and contain costs, Swiss drugmaker Novartis said it will close R&D sites in...

News

Bayer and Evotec in Kidney Disease Pact

04.10.2016 - Bayer and Evotec have signed a five-year multi-research pact to develop multiple clinical candidates to treat chronic kidney diseases. Both of the German companies will contribute...

Markets & Companies

Bridging the Innovation Gap

02.09.2016 - During the last two decades the pharmaceutical industry was forced to undertake significant structural changes to address mounting challenges from strict regulatory policies, lower...